TyRx Pharma, Inc.: Series A $25M

Posted in I - Series A, Q - 1Q08, R - NORTH EAST, X - Drug:Device Combo

TyRx Pharma (Monmouth Junction, NJ) a commercialization-stage developer of implantable drug-device combination products closed a $25M Series A financing. Participants include Clarus Ventures and Pappas Ventures.

PhaseRx, Inc.: Series A $19M

Posted in I - Series A, Q - 1Q08, R - NORTH WEST, X - siRNA

PhaseRx (Seattle, WA) an early-stage siRNA therapeutic company closed a $19M Series A financing. Participants include 5AM Ventures, Arch Venture Partners and Versant Ventures.

Cianna Medical, Inc.: Series A $9M

Posted in I - Series A, Q - 1Q08, R - WEST, X - Oncology

Cianna Medica (Aliso Viejo, CA) a brachytherapy medical device company focused on women’s health and dedicated to the innovative treatment of early-stage breast cancer closed a $9M Series A financing. Participants include BioLucent, Fog City Fund and Windamere Venture Partners.

Obalon Therapeutics, Inc.: Series A $7.7M

Posted in I - Series A, Q - 1Q08, R - WEST, XX - Stealth Mode

Obalon Therapeutics (San Diego, CA) a stealth mode drug startup closed on a $4.7M tranche of a $7.7M Series A financing. Participants include Domain Associates, Okapi Ventures and Phagia Technology Inc.

Affomix, Corp.: Series A $7M

Posted in I - Series A, Q - 1Q08, R - NORTH EAST, X - Antibody, X - Microarray

Affomic (New Haven, CT) a development stage biotechnology company designing antibody microarrays closed a $7M Series A financing. Participants include Connecticut Innovations, Elm Street Ventures, and Four Seasons Ventures.

Nerites Corp.: Series A $5.7Mus

Posted in I - Series A, Q - 1Q08, R - MID WEST, X - Device (Coatings), X - Wound Healing

Nerites (Madison, WI) a development stage company foced on tissue repair products and coatings for medical device coatings closed a $5.7M series A financing. Participants include Venture Investors and Black Mountain Ventures.

Atlas Genetics, Ltd.: Series A $4.1M

Posted in I - Series A, Q - 1Q08, R - INTERNATIONAL, X - Diagnostic

Atlas Genetics (England) developer of point-of-care molecular diagnostics for bacterial and viral disease closed a $4.1M Series A financing. Participants include South West Ventures Fund and Finance South Wales Growth Fund.

Moksha8, Inc.: Series A $24M

Posted in I - Series A, Q - 1Q08, R - WEST, X - Therapeutic Platform

Moksha8 (San Francisco, CA) a diversified commercialization stage company focused on delivery of products to emerging markets closed a combo $24M Series A financing and Series B (see above). Participants include TPG Biotech.

Alverix, Inc.: Series A $7.7M

Posted in I - Series A, Q - 1Q08, R - NORTH EAST, X - Diagnostic

Alverix (Wayne, Pa) developer of point-of-care diagnostics devices closed a $7.7M Series A financing. Participants include New Venture Partners and Safeguard Scientifics.

Traversa Therapeutics, Inc.: Series A $2M

Posted in I - Series A, Q - 1Q08, R - WEST, X - RNAi

Traversa Therapeutics (La Jolla, CA) a discovery and development stage focused on RNAi delivery closed a $2M Series A financing. Participants include San Diego Tech Coast Angels, Mesa Verde Venture Partners and Morningside Group.

« Previous Entries

to top of page...